Article
In vivo mesenchymal stem cell tracking with PET using the dopamine type 2 receptor and 18F-fallypride.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 1 Aug 2014
Schönitzer Veronika, Haasters Florian, Käsbauer Stefanie, Ulrich Veronika, Mille Erik, Gildehaus Franz Josef, Carlsen Janette, Pape Manuela, Beck Roswitha, Delker Andreas, Böning Guido, Mutschler Wolf, Böcker Wolfgang, Schieker Matthias, Bartenstein Peter
Abstract excerpt
UNLABELLED: Human mesenchymal stem cells (hMSCs) represent a promising treatment approach for tissue repair and regeneration. However, little is known about the underlying mechanisms and the fate of the transplanted cells. The objective of the presented work was to determine the feasibility of PET imaging and in vivo monitoring after transplantation of dopamine type 2 receptor-expressing cells. METHODS: An hMSC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
